Cargando…

Triptolide Preserves Cognitive Function and Reduces Neuropathology in a Mouse Model of Alzheimer's Disease

Triptolide, a major bioactive ingredient of a widely used herbal medicine, has been shown to possess multiple pharmacological functions, including potential neuroprotective effects pertinent to Alzheimer's disease (AD) in vitro. However, the therapeutic potential of triptolide for AD in vivo ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Shaowu, LeBlanc, Kyle J., Li, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183525/ https://www.ncbi.nlm.nih.gov/pubmed/25275487 http://dx.doi.org/10.1371/journal.pone.0108845

Ejemplares similares

Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer’s disease mouse model
por: Flores, Joseph, et al.
Publicado: (2018)

Cognitive resilience and severe Alzheimer’s disease neuropathology
por: Ahangari, Narges, et al.
Publicado: (2023)

A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an Alzheimer’s disease mouse model
por: Ortí-Casañ, Natalia, et al.
Publicado: (2022)

Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
por: Flores, Joseph, et al.
Publicado: (2020)

Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
por: Wang, Qi, et al.
Publicado: (2014)

Neuregulin 1 improves cognitive deficits and neuropathology in an Alzheimer’s disease model
por: Xu, Jiqing, et al.
Publicado: (2016)

Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline
por: James, Bryan D., et al.
Publicado: (2019)

Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
por: Uretsky, Madeline, et al.
Publicado: (2021)

Cognitive reserve, neuropathology, and progression towards Alzheimer’s disease
por: Nelson, Monica E., et al.
Publicado: (2023)

Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer’s disease by remodeling peri-plaque astrocyte structure
por: Smith, Alex J., et al.
Publicado: (2019)

Publisher Correction: Pre-symptomatic Caspase-1 inhibitor delays cognitive decline in a mouse model of Alzheimer disease and aging
por: Flores, Joseph, et al.
Publicado: (2021)

Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease
por: Parachikova, Anna, et al.
Publicado: (2010)

Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
por: Smirnov, Denis S., et al.
Publicado: (2022)

Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer's disease
por: Fonseca, Maria I, et al.
Publicado: (2011)

Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines
por: Keene, C. Dirk, et al.
Publicado: (2016)

Magnolol Ameliorates Behavioral Impairments and Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease
por: Xian, Yan-Fang, et al.
Publicado: (2020)

Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer’s Disease
por: Hinteregger, Barbara, et al.
Publicado: (2021)

Effects of triptolide on hippocampal microglial cells and astrocytes in the APP/PS1 double transgenic mouse model of Alzheimer's disease
por: Li, Jian-ming, et al.
Publicado: (2016)

Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer’s disease
por: Fu, Xin-Xin, et al.
Publicado: (2022)

ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer’s disease models
por: Zhao, Yuanyuan, et al.
Publicado: (2022)

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway
por: Yao, Yuyuan, et al.
Publicado: (2022)

Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice
por: Xu, Zhipeng, et al.
Publicado: (2014)

Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
por: Tremblay, Cyntia, et al.
Publicado: (2017)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

Static and Dynamic Cognitive Reserve Proxy Measures: Interactions with Alzheimer’s Disease Neuropathology and Cognition
por: Malek-Ahmadi, Michael, et al.
Publicado: (2017)

Isoflurane mediated neuropathological and cognitive impairments in the triple transgenic Alzheimer’s mouse model are associated with hippocampal synaptic deficits in an age-dependent manner
por: Joseph, Donald J., et al.
Publicado: (2019)

Selenomethionine Ameliorates Neuropathology in the Olfactory Bulb of a Triple Transgenic Mouse Model of Alzheimer’s Disease
por: Zhang, Zhong-Hao, et al.
Publicado: (2016)

Hydrogen-rich water ameliorates neuropathological impairments in a mouse model of Alzheimer's disease through reducing neuroinflammation and modulating intestinal microbiota
por: Lin, Yi-Tong, et al.
Publicado: (2021)

Alzheimer disease models and human neuropathology: similarities and differences
por: Duyckaerts, Charles, et al.
Publicado: (2007)

The Effects of Nebulized Inhaled Triptolide on Airway Inflammation in a Mouse Model of Asthma
por: Miao, Yafang, et al.
Publicado: (2023)

Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity
por: Cheng, Yaxin, et al.
Publicado: (2021)

Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease
por: Zhen, Junli, et al.
Publicado: (2017)

Rational design, cognition and neuropathology evaluation of QTC-4-MeOBnE in a streptozotocin-induced mouse model of sporadic Alzheimer’s disease
por: Fronza, Mariana G., et al.
Publicado: (2019)

The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease
por: Li, Lixia, et al.
Publicado: (2022)

Functional excitatory to inhibitory synaptic imbalance and loss of cognitive performance in people with Alzheimer’s disease neuropathologic change
por: Scaduto, Pietro, et al.
Publicado: (2022)

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease
por: Kalaria, Raj N.
Publicado: (2016)

Multiple comorbid neuropathologies in the setting of Alzheimer's disease neuropathology and implications for drug development
por: Rabinovici, Gil D., et al.
Publicado: (2016)

Effect of canola oil consumption on memory, synapse and neuropathology in the triple transgenic mouse model of Alzheimer’s disease
por: Lauretti, Elisabetta, et al.
Publicado: (2017)

Glucosylceramide synthase inhibition reduces ganglioside GM3 accumulation, alleviates amyloid neuropathology, and stabilizes remote contextual memory in a mouse model of Alzheimer’s disease
por: Dodge, James C., et al.
Publicado: (2022)

Epigenetic Modifications in Alzheimer’s Neuropathology and Therapeutics
por: Esposito, Michelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mignd6lg4jh59rqngkbm26smsa